2022 Endowment Fund Grants: successful grant recipients
We are thrilled to announce that twenty-four innovative Peter Mac cancer research projects have been awarded Peter Mac Foundation Grants thanks to the generosity of donors to the Foundation’s Permanent Endowment Fund.
In total $1.24m in seed funding has been awarded to kick-start these new cancer research projects with the potential to advance cancer research and care.
The twenty-four projects were selected through a rigorous peer review process.
Each project aligns with Peter Mac’s Strategic Directions (2020-2025) and demonstrates the potential to improve health outcomes for people who are at risk of cancer, have cancer or have previously received treatment for cancer.
We are very grateful to the generous individuals who make these annual Grants possible through their gifts to the Foundation's Endowment Fund.
Congratulations to this year’s recipients:
Alice Bergin - Understanding the breast cancer outcome disparity in First Nations women: does disease biology contribute?
Kara Britt - Optimising low-input ChIP-seq analysis on transcription factors
Catherine Devereux - Partnering with consumers to address a “wicked problem”: Enabling end of life conversations between people with cancer and their clinicians.
Abby Douglas - Radiolabelled-siderophore PET/CT for the diagnosis of invasive pulmonary aspergillosis: a pilot study
Cuong Duong - Exploring the use of activity-based fluorescent probes to target oesophageal cancer
Katie Fennell - Establishing a versatile screening tool to identify novel regulators of plasticity in breast cancer
Michelle Gerstman - The impact of inflammation and pharmacogenomics on opioid pharmacokinetics and analgesic response in patients having cancer surgery
Sofya Golenkina & Callum Dark - Identification of biomarkers of cancer-associated cachexia using live human tissue samples
Clare Gould - Novel strategies to predict and monitor response to chimeric antigen receptor (CAR) T-cell therapy in diffuse large B-cell lymphoma
Tony Huang - To investigate the impact of dLN-homing on CAR T cell fitness and positioning using CRISPR-engineering and VISIUM spatial transcriptomics
Lev Kats - Epigenetic therapy for multiple myeloma
Meinir Krishnasamy - “This is Me” - Strengthening the voice of older adults with cancer in multidisciplinary treatment decision making. A feasibility implementation study
Aishwarya Kulkarni - Investigation of first in class Hippo pathway targeted therapies
Annette Lim - Defining immunotherapy resistance mechanisms in cutaneous squamous cell carcinomas.
Susanne Ramm - Development of "Imaging Transcriptomics": A collaborative initiative to enable the integration of high throughput sequencing and imaging in 2D and 3D in vitro models
Aparna Rao - Understanding how glucose fuels the growth and spread of melanoma
Kevin Sek - Fine-tuning adenosine receptor subtype 1 (A1R) CAR T cells to enhance anti-tumour function and effector differentiation against solid tumours
Karen Sheppard - Understanding why some melanomas respond and others don't to immunotherapies
Laure Talarmain - Investigating the role of the Amyloid Precursor Protein in normal and malignant haematopoiesis
Ben Teh - A sero-suvey to investigate immunity and immune response to vaccine preventable infections in the early post autologous haematopoietic stem cell transplant period
Mei Tran - A single-arm feasibility study of a group-based telehealth cognitive behavioural therapy program for insomnia in Vietnamese-speaking cancer survivors
Ilia Voskoboinik - How to curb the cytokine release syndrome in patients undergoing CAR T cell immunotherapy
Madeline Webb - Hippocrates' humors revisited: Does Bile imbalance regulate Cancer-Associated Cachexia?
William Hamilton - Proteomic screening of spliceosomal mutations in myelodysplastic syndromes